Ten questions to ask before deciding on any cell therapy

Suitability depends on the condition, cell type, plans permitted under Korean law, and an individual assessment. The EHL team reviews your health information and explains the available options before confirming a care plan.

Ask: (1) what standard treatment for my condition have I not yet tried; (2) what research stage is cell therapy at in this disease; (3) is this a registered study or a commercial service; (4) who manufactures the cells and in what standard of facility; (5) is release testing documentation available; (6) what outcome does the evidence support, as opposed to the marketing; (7) what risks and complications have been reported; (8) must I stop current medication, and who is responsible if the disease flares; (9) how is long-term follow-up handled; and (10) what does the total cost include. Any answer that guarantees results, or that avoids the question of quality documentation, is a clear warning sign.

Source: ClinicalTrials.gov